Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 25% ± 8% | |
brain | 13 studies | 32% ± 15% | |
eye | 9 studies | 28% ± 11% | |
intestine | 5 studies | 23% ± 7% | |
kidney | 5 studies | 20% ± 4% | |
heart | 5 studies | 27% ± 7% | |
breast | 5 studies | 24% ± 4% | |
pancreas | 4 studies | 43% ± 20% | |
adipose | 4 studies | 32% ± 11% | |
peripheral blood | 3 studies | 20% ± 1% | |
uterus | 3 studies | 41% ± 4% | |
liver | 3 studies | 34% ± 7% | |
skin | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 15900.72 | 258 / 258 | 100% | 61.92 | 230 / 230 |
esophagus | 100% | 17697.91 | 1445 / 1445 | 100% | 90.08 | 183 / 183 |
prostate | 100% | 14191.46 | 245 / 245 | 100% | 77.58 | 502 / 502 |
thymus | 100% | 12108.68 | 652 / 653 | 100% | 71.01 | 605 / 605 |
ovary | 100% | 16484.96 | 180 / 180 | 100% | 76.54 | 428 / 430 |
breast | 100% | 12768.01 | 459 / 459 | 99% | 79.72 | 1107 / 1118 |
skin | 100% | 12654.80 | 1808 / 1809 | 99% | 49.56 | 467 / 472 |
kidney | 100% | 6682.29 | 89 / 89 | 98% | 50.23 | 887 / 901 |
pancreas | 100% | 11629.94 | 328 / 328 | 98% | 43.19 | 175 / 178 |
liver | 100% | 9526.15 | 226 / 226 | 98% | 48.87 | 397 / 406 |
brain | 98% | 6951.02 | 2588 / 2642 | 99% | 65.08 | 701 / 705 |
uterus | 100% | 17517.76 | 170 / 170 | 97% | 46.89 | 444 / 459 |
lung | 100% | 11130.22 | 578 / 578 | 97% | 46.15 | 1116 / 1155 |
stomach | 100% | 11262.06 | 359 / 359 | 92% | 49.47 | 262 / 286 |
intestine | 100% | 13260.55 | 962 / 966 | 88% | 32.17 | 462 / 527 |
bladder | 100% | 14554.19 | 21 / 21 | 87% | 25.79 | 436 / 504 |
adipose | 100% | 12220.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 16717.43 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 51.75 | 80 / 80 |
muscle | 100% | 37009.75 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.57 | 1 / 1 |
heart | 99% | 11667.85 | 849 / 861 | 0% | 0 | 0 / 0 |
spleen | 98% | 5046.55 | 237 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 48.77 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 76% | 12.44 | 22 / 29 |
peripheral blood | 25% | 823.00 | 230 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006260 | Biological process | DNA replication |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001650 | Cellular component | fibrillar center |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | NFIC |
Protein name | Nuclear factor 1 Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein) |
Synonyms | NFI |
Description | FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . |
Accessions | ENST00000586919.5 [P08651-4] ENST00000590282.5 [P08651-6] A0A286YEX4 ENST00000395111.7 [P08651-3] Q6FI30 ENST00000641145.1 ENST00000443272.3 [P08651-1] P08651 ENST00000589123.5 [P08651-2] ENST00000341919.7 [P08651-5] |